Three newer migraine drugs were included in the analysis: lasmiditan (Reyvow), rimegepant (Nurtec), and ubrogepant (Ubrelvy).

An NIH-supported clinical trial of pomalidomide in treating hereditary hemorrhagic telangiectasia stopped early due to ...

With more than 300 patients in the trial, dubbed FOREMOST, 33.9% of those assigned to apremilast achieved minimal disease ...

Obermair calls for his fellow gynecological cancer surgeons to join him in interrogating current standards of practice.

This gives rise to questions regarding what types of employment opportunities or interventions can draw women into work in such contexts. In this study in urban Djibouti, with restrictive gender norms ...

In an interview with Targeted Oncology, Mark R. Litzow, MD, discussed the incorporation of Immunotherapy into upfront acute ...

High-dose vitamin D added to chemotherapy failed to provide a benefit in patients with metastatic colorectal cancer in the ...

Christopher Granger, MD, Gregg Fonarow, MD, and Carlin S Long, MD, discuss the use of beta-blocker therapy following acute MI ...

Three different doses of Niktimvo all had high rates of response among patients with recurrent or refractory ...

Dupilumab decreases general and type 2 inflammatory biomarker levels in children with moderate to severe atopic dermatitis.

Strategically incorporating color in health care spaces can potentially increase patient comfort and improve overall satisfaction.